Advancements in Small-Cell Lung Cancer Treatment
Advancements in Small-Cell Lung Cancer Treatment
Created using ChatSlide
This overview addresses the clinical context of small cell lung cancer (SCLC) and the unmet need for effective consolidation therapies following aggressive disease and relapse after concurrent chemoradiotherapy (cCRT). It discusses prior standards, including the significance of concurrent chemoradiotherapy and the CONVERT trial. The ADRIATIC trial is highlighted, detailing its design, patient population, endpoints, and efficacy results, showing improved overall and progression-free survival...